loading
Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché RLAY Giù? Forum Previsione
Precedente Chiudi:
$4.66
Aprire:
$4.66
Volume 24 ore:
139.02K
Relative Volume:
0.07
Capitalizzazione di mercato:
$780.00M
Reddito:
$25.55M
Utile/perdita netta:
$-341.97M
Rapporto P/E:
-1.6989
EPS:
-2.69
Flusso di cassa netto:
$-304.44M
1 W Prestazione:
-19.29%
1M Prestazione:
-29.70%
6M Prestazione:
-40.21%
1 anno Prestazione:
-43.22%
Intervallo 1D:
Value
$4.48
$4.715
Intervallo di 1 settimana:
Value
$4.48
$5.63
Portata 52W:
Value
$4.48
$12.14

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
Nome
Relay Therapeutics Inc
Name
Settore
Healthcare (1195)
Name
Industria
Biotechnology (683)
Name
Telefono
617-370-8837
Name
Indirizzo
399 BINNEY STREET, CAMBRIDGE
Name
Dipendente
294
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
RLAY's Discussions on Twitter

Confronta RLAY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
RLAY 4.54 780.00M 25.55M -341.97M -304.44M -2.69
VRTX 447.00 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.05 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 586.52 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.92 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.72 24.49B 3.30B -501.07M 1.03B 11.54

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-04-20 Aggiornamento Jefferies Underperform → Hold
2023-04-19 Aggiornamento Raymond James Outperform → Strong Buy
2023-04-13 Iniziato Raymond James Outperform
2023-02-03 Iniziato Oppenheimer Outperform
2022-09-30 Iniziato Barclays Equal Weight
2022-09-02 Iniziato Stifel Buy
2022-06-06 Iniziato Jefferies Underperform
2022-02-01 Iniziato Berenberg Buy
2021-07-21 Iniziato BofA Securities Buy
2020-12-15 Reiterato H.C. Wainwright Buy
2020-12-08 Iniziato JMP Securities Mkt Outperform
2020-11-05 Iniziato H.C. Wainwright Buy
2020-08-10 Iniziato Cowen Outperform
2020-08-10 Iniziato Goldman Buy
2020-08-10 Iniziato Guggenheim Buy
2020-08-10 Iniziato JP Morgan Neutral
Mostra tutto

Relay Therapeutics Inc Borsa (RLAY) Ultime notizie

pulisher
Nov 20, 2024

Down -27.93% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround - Yahoo Finance

Nov 20, 2024
pulisher
Nov 19, 2024

Down -23.95% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

First Turn Management LLC Buys New Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace

Nov 18, 2024
pulisher
Nov 17, 2024

Relay Therapeutics (NASDAQ:RLAY) Trading Down 4.8% – Here’s What Happened - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

Relay Therapeutics (NASDAQ:RLAY) Stock Price Down 4.8%Time to Sell? - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

(RLAY) Trading Report - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 14, 2024

Relay Therapeutics stock hits 52-week low at $5.59 - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

Relay Therapeutics stock hits 52-week low at $5.59 By Investing.com - Investing.com UK

Nov 14, 2024
pulisher
Nov 14, 2024

Analyzing Valneva (NASDAQ:VALN) and Relay Therapeutics (NASDAQ:RLAY) - Defense World

Nov 14, 2024
pulisher
Nov 14, 2024

NKGen Biotech (NYSE:NKGN) versus Relay Therapeutics (NASDAQ:RLAY) Financial Contrast - Defense World

Nov 14, 2024
pulisher
Nov 13, 2024

Relay Therapeutics' SWOT analysis: PI3K inhibitor progress fuels stock potential - Investing.com

Nov 13, 2024
pulisher
Nov 12, 2024

HC Wainwright Forecasts Strong Price Appreciation for Relay Therapeutics (NASDAQ:RLAY) Stock - Defense World

Nov 12, 2024
pulisher
Nov 11, 2024

Research Analysts Offer Predictions for RLAY FY2024 Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

FY2024 Earnings Estimate for RLAY Issued By Leerink Partnrs - Defense World

Nov 11, 2024
pulisher
Nov 09, 2024

Relay Therapeutics (NASDAQ:RLAY) Given New $20.00 Price Target at HC Wainwright - MarketBeat

Nov 09, 2024
pulisher
Nov 07, 2024

Relay Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

RLAYRelay Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Relay Therapeutics Reports Q3 2024 Results and Advances - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Relay Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024
pulisher
Nov 04, 2024

Where are the Opportunities in (RLAY) - Stock Traders Daily

Nov 04, 2024
pulisher
Oct 31, 2024

Relay Therapeutics (RLAY) to Release Earnings on Wednesday - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts - Investing.com Australia

Oct 31, 2024
pulisher
Oct 30, 2024

Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024 - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, - EIN News

Oct 30, 2024
pulisher
Oct 29, 2024

Intrahepatic Cholangiocarcinoma Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapy - Barchart

Oct 29, 2024
pulisher
Oct 28, 2024

Institutional owners may consider drastic measures as Relay Therapeutics, Inc.'s (NASDAQ:RLAY) recent US$67m drop adds to long-term losses - Yahoo Finance

Oct 28, 2024
pulisher
Oct 28, 2024

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Oct 28, 2024
pulisher
Oct 25, 2024

Several Relay Therapeutics Insiders Sell Shares Sending Potential Negative Signal - Simply Wall St

Oct 25, 2024
pulisher
Oct 25, 2024

Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase - Investing.com Canada

Oct 25, 2024
pulisher
Oct 24, 2024

Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 16, 2024

Financial Snapshot: Analyzing Relay Therapeutics Inc (RLAY)’s Key Ratio Metrics - The Dwinnex

Oct 16, 2024
pulisher
Oct 15, 2024

Relay Therapeutics, Inc. (NASDAQ:RLAY) Short Interest Update - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

How did Relay Therapeutics Inc (RLAY) fare last session? - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Relay Therapeutics (NASDAQ:RLAY) Receives Buy Rating from HC Wainwright - MarketBeat

Oct 14, 2024
pulisher
Oct 14, 2024

Relay Therapeutics stock holds price target on FDA approval By Investing.com - Investing.com UK

Oct 14, 2024
pulisher
Oct 14, 2024

Relay Therapeutics Inc (RLAY) receives a Buy rating from Jefferies - Knox Daily

Oct 14, 2024

Relay Therapeutics Inc Azioni (RLAY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Relay Therapeutics Inc Azioni (RLAY) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Catinazzo Thomas
Chief Financial Officer
Oct 28 '24
Sale
6.06
6,802
41,220
306,391
Catinazzo Thomas
Chief Financial Officer
Oct 29 '24
Sale
5.95
2,300
13,685
304,091
Bergstrom Donald A
President, R&D
Oct 28 '24
Sale
6.06
2,688
16,289
520,745
Adams Brian
Chief Legal Officer
Oct 28 '24
Sale
6.06
1,632
9,890
321,907

Simile a RLAY

biotechnology INCY
$70.68
price down icon 0.42%
biotechnology SMMT
$18.62
price up icon 0.16%
biotechnology MRNA
$36.06
price down icon 1.68%
biotechnology UTHR
$364.60
price up icon 0.01%
biotechnology BGNE
$196.58
price up icon 0.88%
biotechnology BNTX
$102.64
price up icon 0.27%
Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters
Capitalizzazione:     |  Volume (24 ore):